Literature DB >> 15943467

Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.

Anne Vessières1, Siden Top, Pascal Pigeon, Elizabeth Hillard, Leila Boubeker, Daniela Spera, Gérard Jaouen.   

Abstract

We report here the synthesis and the strong and unexpected antiproliferative effect of the organometallic diphenolic compound 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (4) on both hormone-dependent (MCF7) and -independent (MDA-MB231) breast cancer cells (IC(50) = 0.7 and 0.6 microM). Surprisingly, 6 [1,2-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene], the regioisomer of 4, shows only a modest effect on these cell lines. This pertinent organometallic modification seems to trigger an intracellular oxidation of the structurally favorable compound 4, leading to the generation of a potent cytotoxic compound.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943467     DOI: 10.1021/jm050251o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Synthesis of hydroxyferrocifen and its abilities to protect DNA and to scavenge radicals.

Authors:  Feng Zhao; Chao Zhao; Zai-Qun Liu
Journal:  J Biol Inorg Chem       Date:  2011-06-24       Impact factor: 3.358

2.  Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies.

Authors:  José Vera; Li Ming Gao; Alberto Santana; Jaime Matta; Enrique Meléndez
Journal:  Dalton Trans       Date:  2011-08-18       Impact factor: 4.390

3.  Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.

Authors:  Emilie Allard; Delphine Jarnet; Anne Vessières; Sandrine Vinchon-Petit; Gérard Jaouen; Jean-Pierre Benoit; Catherine Passirani
Journal:  Pharm Res       Date:  2009-11-12       Impact factor: 4.200

4.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors:  Xiaohua Peng; Varsha Gandhi
Journal:  Ther Deliv       Date:  2012-07

5.  Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties.

Authors:  E R Milaeva; S I Filimonova; N N Meleshonkova; L G Dubova; E F Shevtsova; S O Bachurin; N S Zefirov
Journal:  Bioinorg Chem Appl       Date:  2010-06-09       Impact factor: 7.778

6.  Functionalized ferrocenes: The role of the para substituent on the phenoxy pendant group.

Authors:  José L Vera; Jorge Rullán; Natasha Santos; Jesús Jiménez; Joshua Rivera; Alberto Santana; Jon Briggs; Arnold L Rheingold; Jaime Matta; Enrique Meléndez
Journal:  J Organomet Chem       Date:  2014-01-01       Impact factor: 2.369

Review 7.  Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

Authors:  Sabine H van Rijt; Peter J Sadler
Journal:  Drug Discov Today       Date:  2009-09-24       Impact factor: 7.851

8.  Synthesis and biological evaluation of novel ferrocenyl curcuminoid derivatives.

Authors:  Anusch Arezki; Guy Chabot; Lionel Quentin; Daniel Scherman; Gérard Jaouen; Emilie Brulé
Journal:  Medchemcomm       Date:  2011-01-11       Impact factor: 3.597

9.  Catalytic organometallic anticancer complexes.

Authors:  Sarah J Dougan; Abraha Habtemariam; Sarah E McHale; Simon Parsons; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

10.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.